Tebentafusp Clinical Trials
8 recruitingDrug
Phase 25Phase 32Phase 11
Showing 1–8 of 8 trials
Recruiting
Phase 2
Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
H. Lee Moffitt Cancer Center and Research Institute18 enrolled1 locationNCT07276386
Recruiting
Phase 2
Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
Mestastatic Uveal Melanoma
Grupo Español Multidisciplinar de Melanoma19 enrolled4 locationsNCT07057596
Recruiting
Phase 3
Adjuvant Tebentafusp in High Risk Ocular Melanoma
Uveal Melanoma
European Organisation for Research and Treatment of Cancer - EORTC290 enrolled14 locationsNCT06246149
Recruiting
Phase 2
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
Uveal Melanoma
Diwakar Davar44 enrolled3 locationsNCT06070012
Recruiting
Phase 3
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Advanced Melanoma
Immunocore Ltd540 enrolled82 locationsNCT05549297
Recruiting
Phase 2
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma
Metastatic Uveal MelanomaMetastatic Uveal Melanoma in the Liver
University of Miami30 enrolled1 locationNCT06627244
Recruiting
Phase 2
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
HLA-A*0201 Positive Cells PresentClear Cell Sarcoma (CCS)
Sarcoma Alliance for Research through Collaboration47 enrolled2 locationsNCT06942442
Recruiting
Phase 1
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
Advanced or Metastatic Solid Tumors
DynamiCure Biotechnology320 enrolled35 locationsNCT05785754